Search Results

so used in certain veterinary and human pharmaceuticals.    Key Objectives of the New

of environmental risks associated with pharmaceuticals and establishing a modernized regulato

Distribution, and/or Transportation for pharmaceutical companies and manufacturers of medical

us applications and industries, such as pharmaceuticals, agrochemicals, polymers and many othe

l medicine and quasi-drugs defined in ˹Pharmaceutical Affairs Act˼ Narcotics defined in ˹

lation, CSAR), the National Medical and Pharmaceutical Agency (NMPA) published the good manufa

yearly. It also aimed to delist 125 pharmaceutical ingredients that were discontinued orÂ

·       The National Pharmaceutical Pricing Authority (NPPA) will be streng

on of perfluorooctyl bromide (PFOB) for pharmaceutical products. 8:2 fluorotelomer alcohol (

produced in the manufacture of paints, pharmaceuticals, and refrigerants. Under the Clean

luding waste management, cosmetics, and pharmaceuticals, to ensure legal clarity and prevent m

ing and approving guidelines and use of pharmaceutical drugs, sanitary standards, and regulati

door use. Medical applications: Pharmaceutical packaging and excipients. Print

technical rubber accessories.  Pharmaceutical: antibiotic products; raw materials pr

On 6 July 2022 Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) has restricted th

its safe use in contact with foodstuffs pharmaceuticals and drinking water’. The consultatio

widely used in the manufacture of dyes, pharmaceuticals, and perfumes. 

es include key precursors often used in pharmaceutical and chemical production but with potent

and 26 Dec. 2022, National Medical and Pharmaceutical Administration of China (NMPA) released

On 9 December 2022 the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia published